NR
HOLX

Newfound Research’s Hologic HOLX Stock Holding History

Newfound Research’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$81K Buy
1,257
+75
+6% +$5.2K 0.2% 42
2022
Q2 		$82K Buy
+1,182
New +$87.7K 0.17% 78

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Newfound Research's HOLX Position: Q3 2022 in Review

Newfound Research increased its Hologic (HOLX) stake by 6.3% in Q3 2022, buying an estimated $5.2K and bringing the position to 1,257 shares worth $81K. The position accounts for 0.2% of the portfolio, ranked #42.

Newfound Research first reported a position in HOLX in Q2 2022 and has held it in 2 quarters since. The position peaked at $82K in Q2 2022. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Newfound Research held 1,257 shares of Hologic worth $81K as of Q3 2022.
  • Newfound Research bought 75 Hologic shares in Q3 2022, an estimated $5.2K.
  • Hologic made up 0.2% of Newfound Research's portfolio in Q3 2022, its #42 holding.
  • Newfound Research first reported a position in Hologic in Q2 2022 and has held it in 2 quarters since.
  • Newfound Research's Hologic position peaked at $82K in Q2 2022.
  • 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.